The Manufacturers Life Insurance Company Raises Position in MiMedx Group, Inc. (NASDAQ:MDXG)

The Manufacturers Life Insurance Company raised its stake in shares of MiMedx Group, Inc. (NASDAQ:MDXG) by 35.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 61,706 shares of the company’s stock after purchasing an additional 16,083 shares during the period. The Manufacturers Life Insurance Company’s holdings in MiMedx Group were worth $365,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC raised its holdings in shares of MiMedx Group by 1.0% in the third quarter. Allspring Global Investments Holdings LLC now owns 183,021 shares of the company’s stock worth $1,082,000 after buying an additional 1,822 shares during the period. Hsbc Holdings PLC raised its holdings in shares of MiMedx Group by 7.3% in the second quarter. Hsbc Holdings PLC now owns 34,343 shares of the company’s stock worth $233,000 after buying an additional 2,329 shares during the period. Marshall Wace LLP raised its holdings in shares of MiMedx Group by 1.1% in the second quarter. Marshall Wace LLP now owns 298,818 shares of the company’s stock worth $2,071,000 after buying an additional 3,223 shares during the period. Principal Financial Group Inc. raised its holdings in shares of MiMedx Group by 6.3% in the third quarter. Principal Financial Group Inc. now owns 55,495 shares of the company’s stock worth $328,000 after buying an additional 3,292 shares during the period. Finally, Victory Capital Management Inc. raised its holdings in shares of MiMedx Group by 2.8% in the third quarter. Victory Capital Management Inc. now owns 142,350 shares of the company’s stock worth $841,000 after buying an additional 3,901 shares during the period. 79.15% of the stock is currently owned by hedge funds and other institutional investors.

MiMedx Group Stock Down 3.0 %

Shares of NASDAQ:MDXG opened at $9.16 on Monday. MiMedx Group, Inc. has a 52-week low of $5.47 and a 52-week high of $10.14. The stock has a market cap of $1.35 billion, a P/E ratio of 16.65 and a beta of 1.98. The business’s 50 day moving average is $7.64 and its 200 day moving average is $7.02. The company has a quick ratio of 3.53, a current ratio of 4.10 and a debt-to-equity ratio of 0.10.

Analyst Ratings Changes

Separately, StockNews.com cut MiMedx Group from a “strong-buy” rating to a “buy” rating in a research note on Friday, November 8th. Six equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $12.00.

MiMedx Group Profile

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins.